首页 | 本学科首页   官方微博 | 高级检索  
检索        


Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas
Authors:Jerome L Belinson MD  James A Stewart MD  Audrey L Richards BA  Maura McClure RN
Institution:1. Department of Obstetrics and Gynecology of the Medical Center Hospital of Vermont, Vermont Regional Cancer Center University of Vermont College of Medicine, Burlington, Vermont 05401 USA;2. Department of Medicine, Medical Oncology Unit, University of Vermont College of Medicine, Vermont Regional Cancer Center University of Vermont College of Medicine, Burlington, Vermont 05401 USA;3. Department of Obstetrics and Gynecology of the Medical Center Hospital of Vermont, University of Vermont College of Medicine, Burlington, Vermont 05401 USA
Abstract:Twenty-one patients with squamous carcinoma of the genital tract were treated with bleomycin, Oncovin, mitomycin-C, and cisplatin (BOMP). Six patients received BOMP as primary therapy. Five of six responded with one patient having an autopsy-proven complete response after treatment for a disseminated adenosquamous carcinoma. Eight patients were treated for early recurrence, none responded. Seven patients were treated for late recurrences and one responded. We believe that BOMP has significant potential for primary treatment, but not for early or late recurrent disease.
Keywords:Chem  chemotherapy  Rad  radiotherapy  Surg  surgery  CR  complete response  PR  partial response  PD  progressive disease  SD  stable disease  A  alive  D  dead
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号